Addressing Global Disparities in Lung Cancer Screening: Lessons From Puerto Rico and Beyond

Lung cancer screening (LCS) has been proven to reduce mortality by detecting lung cancer at early stages. It has been available in the United States since its pioneering recommendation by the U.S. Preventive Services Task Force more than a decade ago.1 Fundamentally, screening can only benefit people who participate. Despite its early adoption in the United States, LCS uptake rates have lagged behind ambition.